BioLine RX Ltd (BLRX) — Net Asset Quality Index
BioLine RX Ltd (BLRX) has a Net Asset Quality Index of 49.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA39.80 Million minus total liabilities of ILA20.27 Million yields net assets of ILA19.53 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read BioLine RX Ltd (BLRX) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
BioLine RX Ltd Net Asset Quality Index Over Time (2005–2024)
This chart shows how BioLine RX Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the index stands at 49.1%, representing net assets of ILA19.53 Million against total assets of ILA39.80 Million ILA. For live market cap and overall valuation, see BioLine RX Ltd market cap and net worth.
Annual Net Asset Quality Index for BioLine RX Ltd (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for BioLine RX Ltd from 2005 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BLRX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 34.6% | ILA13.46 Million | ILA38.91 Million | ILA25.45 Million | ▲ +13.9 pp |
| 2023 | 20.7% | ILA13.22 Million | ILA63.92 Million | ILA50.70 Million | ▼ -45.9 pp |
| 2022 | 66.6% | ILA50.84 Million | ILA76.38 Million | ILA25.54 Million | ▼ -17.1 pp |
| 2021 | 83.7% | ILA68.09 Million | ILA81.39 Million | ILA13.30 Million | ▲ +37.1 pp |
| 2020 | 46.6% | ILA22.03 Million | ILA47.29 Million | ILA25.26 Million | ▼ -15.7 pp |
| 2019 | 62.3% | ILA33.38 Million | ILA53.57 Million | ILA20.19 Million | ▼ -11.2 pp |
| 2018 | 73.5% | ILA41.32 Million | ILA56.23 Million | ILA14.91 Million | ▼ -13.3 pp |
| 2017 | 86.7% | ILA52.88 Million | ILA60.97 Million | ILA8.08 Million | ▼ -3.2 pp |
| 2016 | 90.0% | ILA35.03 Million | ILA38.94 Million | ILA3.91 Million | ▼ -2.8 pp |
| 2015 | 92.8% | ILA47.61 Million | ILA51.30 Million | ILA3.69 Million | ▲ +5.0 pp |
| 2014 | 87.8% | ILA31.77 Million | ILA36.17 Million | ILA4.40 Million | ▲ +29.3 pp |
| 2013 | 58.6% | ILA11.68 Million | ILA19.95 Million | ILA8.27 Million | ▼ -3.0 pp |
| 2012 | 61.6% | ILA14.97 Million | ILA24.31 Million | ILA9.34 Million | ▼ -15.2 pp |
| 2011 | 76.8% | ILA22.53 Million | ILA29.34 Million | ILA6.81 Million | ▼ -8.5 pp |
| 2010 | 85.3% | ILA131.96 Million | ILA154.61 Million | ILA22.65 Million | ▲ +11.3 pp |
| 2009 | 74.1% | ILA117.94 Million | ILA159.17 Million | ILA41.23 Million | ▲ +6.4 pp |
| 2008 | 67.7% | ILA78.39 Million | ILA115.73 Million | ILA37.34 Million | ▼ -20.4 pp |
| 2007 | 88.2% | ILA183.25 Million | ILA207.88 Million | ILA24.63 Million | ▲ +94.3 pp |
| 2006 | -6.2% | ILA-1.25 Million | ILA20.12 Million | ILA21.37 Million | ▼ -68.2 pp |
| 2005 | 62.0% | ILA12.77 Million | ILA20.59 Million | ILA7.83 Million | — |